1887
Perspective Open Access
Like 0

Abstract

Defined daily doses (DDD) are the gold standard indicator for quantifying prescriptions. Since 2014, the European Centre for Disease Prevention and Control (ECDC) has also been using the number of packages per 1,000 inhabitants per day (ipd), as a surrogate for prescriptions, to report antibiotic consumption in the community and to perform comparisons between European Union (EU) countries participating in the European Surveillance of Antimicrobial Consumption Network (ESAC-Net). In 2015, consumption was reported to range across Europe from 1.0 to 4.7 packages per 1,000 ipd. Our analysis showed that consumption of antibiotics for systemic use per 1,000 ipd was on average 1.3 times greater in France than in Belgium when considering prescriptions in the numerator, 2.5 times greater when considering packages and 1.2 times greater when considering DDD. As long as the same metrics are used over time, antibiotic consumption data aggregated and disseminated by ECDC are useful for assessing temporal trends at the European level and within individual countries; these data may also be used for benchmarking across EU countries. While DDD - although imperfect - are the most widely accepted metric for this purpose, antibiotic packages do not appear suitable for comparisons between countries and may be misleading.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2017.22.46.17-00352
2017-11-16
2017-12-11
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2017.22.46.17-00352
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/22/46/eurosurv-22-46-5.html?itemId=/content/10.2807/1560-7917.ES.2017.22.46.17-00352&mimeType=html&fmt=ahah

References

  1. ATC/DDD Index. 2017. Oslo: World Health Organization Collaborating Centre for Drug Statistics Methodology; December 2016. Available from: https://www.whocc.no/atc_ddd_index/
  2. European Centre for Disease Prevention and Control (ECDC). Summary of the latest data on antibiotic consumption in the European Union. November 2014. Stockholm: ECDC; 2014. Available from: https://ecdc.europa.eu/sites/portal/files/documents/antibiotics-consumption-EU-data-2014.pdf
  3. European Centre for Disease Prevention and Control (ECDC). Summary of the latest data on antibiotic consumption in the European Union. November 2015. Stockholm: ECDC; 2015. Available from: https://ecdc.europa.eu/sites/portal/files/documents/antibiotics-consumption-EU-data-2015.pdf
  4. European Centre for Disease Prevention and Control (ECDC). Summary of the latest data on antibiotic consumption in the European Union. ESAC-Net surveillance data, November 2016. Stockholm: ECDC; 2016. Available from: https://ecdc.europa.eu/sites/portal/files/documents/antibiotics-ESAC-Net%20Summary%202016_0.pdf
  5. Davey P, Ferech M, Ansari F, Muller A, Goossens HESAC Project Group. Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysis. J Antimicrob Chemother. 2008;62(6):1441-7.  https://doi.org/10.1093/jac/dkn386  PMID: 18786937 
  6. Campos J, Ferech M, Lázaro E, de Abajo F, Oteo J, Stephens P, et al. Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother. 2007;60(3):698-701.  https://doi.org/10.1093/jac/dkm248  PMID: 17616551 
  7. Sabuncu E, David J, Bernède-Bauduin C, Pépin S, Leroy M, Boëlle P-Y, et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med. 2009;6(6):e1000084.  https://doi.org/10.1371/journal.pmed.1000084  PMID: 19492093 
  8. Coenen S, Gielen B, Blommaert A, Beutels P, Hens N, Goossens H. Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of different measures. J Antimicrob Chemother. 2014;69(2):529-34.  https://doi.org/10.1093/jac/dkt385  PMID: 24084641 
  9. Institut national de la statistique et des études économiques (Insee). Population totale au 1er janvier – France métropolitaine. [Total population on 1 January – mainland France]. Paris: Insee. [Accessed: 26 Sep 2017]. French. Available from: https://www.insee.fr/fr/statistiques/serie/000067670
  10. Base de données publique des médicaments. [Public drug database]. Paris: Ministère des solidarités et de la santé. [Accessed: 26 Sep 2017]. 2017. French. Available from: http://base-donnees-publique.medicaments.gouv.fr/
  11. Centre Belge d'Information Pharmacothérapeutique (CBIP). Répertoire commenté des Médicaments. [Commented directory of drugs]. Gent: CBIP; 2017. French. Available from: http://www.cbip.be/fr/chapters
  12. Belgian Antibiotic Policy Coordination Committee (BAPCOC). Guide Belge des traitements anti-infectieux en pratique ambulatoire. [Belgian guide to anti-infective treatments in outpatient practice]. Brussels: BAPCOC; 2012. French. Available from: http://www.cbip.be/legacy_assets/antibioticagids-fr.pdf
  13. Société de pathologie infectieuse de langue française (Spilf), Agence française de sécurité sanitaire des produits de santé (AFSSAPS), Société de pneumologie de langue française (SPLF). Mise au point. Antibiothérapie par voie générale dans les infections respiratoires basses de l’adulte. [Focus. General antibiotic therapy in lower respiratory tract infections in adults]. Saint-Denis Cedex: AFSSAPS; 2010. French. Available from: http://www.infectiologie.com/UserFiles/File/medias/_documents/consensus/2010-infVRB-spilf-afssaps.pdf
  14. Cižman M. Measurement units for antibiotic consumption in outpatients. J Antimicrob Chemother. 2014;69(10):2877-8.  https://doi.org/10.1093/jac/dku194  PMID: 24898018 
  15. Coenen S, Bruyndonckx R, Hens N, Aerts M, Goossens H. Comment on: Measurement units for antibiotic consumption in outpatients. J Antimicrob Chemother. 2014;69(12):3445-6.  https://doi.org/10.1093/jac/dku292  PMID: 25204344 
  16. Bruyndonckx R, Hens N, Aerts M, Goossens H, Molenberghs G, Coenen S. Measuring trends of outpatient antibiotic use in Europe: jointly modelling longitudinal data in defined daily doses and packages. J Antimicrob Chemother. 2014;69(7):1981-6.  https://doi.org/10.1093/jac/dku063  PMID: 24623832 
  17. Bruyndonckx R, Hens N, Aerts M, Goossens H, Cortiñas Abrahantes J, Coenen S. Exploring the association between resistance and outpatient antibiotic use expressed as DDDs or packages. J Antimicrob Chemother. 2015;70(4):1241-4.  https://doi.org/10.1093/jac/dku525  PMID: 25585511 
  18. DRIVE AB WP-1A: Quality indicators and quantity metrics of antibiotic use. [Accessed: 26 Sep 2017]. Available from: http://drive-ab.eu/wp-content/uploads/2014/09/WP1A_Final-QMs-QIs_final.pdf
  19. Centers for Disease Control and Prevention (CDC). Antibiotic use in the United States, 2017: progress and opportunities. Atlanta: CDC; 2017. Available from: https://www.cdc.gov/antibiotic-use/stewardship-report/pdf/stewardship-report.pdf
  20. Coenen S, Ferech M, Haaijer-Ruskamp FM, Butler CC, Vander Stichele RH, Verheij TJM, et al. European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care. 2007;16(6):440-5.  https://doi.org/10.1136/qshc.2006.021121  PMID: 18055888 
/content/10.2807/1560-7917.ES.2017.22.46.17-00352
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error